MAP2 and depressive disorder: As the current study demonstrated that decreases in MAP2, a protein expressed in dendrites, was observed within the CA1 and CA3 sub-regions of the hippocampus, this aligns with previous psychiatric studies showing the significant role the pathophysiology of the hippocampus plays in depression.